(TNS) Deliberation over a proposal to invest state money in clinical research of a psychedelic drug as a potential treatment for opioid addiction is intensifying.
“It does have a certain attractiveness to think if you could give a single dose of a drug, that could give a lifetime cure,” said Dr. Mark Haigney, but, “My opinion is ibogaine is not safe.”